Onyx Pharmaceuticals Announces Teleconference to Provide Status Update on C... ( EMERYVILLE Calif. Oct. 7 /- Onyx Phar...)

Onyx Pharmaceuticals Announces Teleconference to Provide Status Update on Carfilzomib

Date:10/7/2010

EMERYVILLE, Calif., Oct. 7 /PRNewswire/ -- Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced that management will host a teleconference to provide a status update on its New Drug Application (NDA) for carfilzomib. Interested parties may access a live webcast of the presentation on our website at:

http://www.onyx-pharm.com/view.cfm/32/Event-Calendar

or by dialing 847-585-4405 and using the passcode 28119641. A replay of the presentation will be available on the Onyx website or by dialing 630-652-3042 and using the passcode 28119641# approximately one hour after the teleconference concludes. The replay will be available through October 21, 2010.

About Onyx Pharmaceuticals, Inc.

Onyx Pharmaceuticals, Inc. is a biopharmaceutical company committed to improving the lives of people with cancer. The company, in collaboration with Bayer HealthCare Pharmaceuticals Inc., is developing and marketing Nexavar® (sorafenib) tablets, a small molecule drug that is currently approved for the treatment of liver cancer and advanced kidney cancer. Additionally, Nexavar is being investigated in several ongoing trials in a variety of tumor types. Beyond Nexavar, Onyx has established a development pipeline of anticancer compounds at various stages of clinical testing, including carfilzomib, a proteasome inhibitor, that is currently being evaluated in multiple clinical trials for the treatment of patients with relapsed or relapsed/refractory multiple myeloma and solid tumors. ONX 0801, an alpha-folate receptor targeted inhibitor of thymidylate synthase, and ONX 0912, an oral proteasome inhibitor, are currently in Phase 1 testing. For more information about Onyx, visit the company's website at www.onyx-pharm.com.

Nexavar® (s
'/>"/>

SOURCE Onyx Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related medicine technology :

1. Star Scientific Comments on Roskamp Institutes Plans to Conduct Human Alzheimers Clinical Trials Using a Compound (RCP-006) Developed by Rock Creek Pharmaceuticals, Inc.
2. VentiRx Pharmaceuticals Reports Positive Clinical Data for VTX-1463 in Allergic Rhinitis
3. Regeneron Pharmaceuticals, Inc. Announces The Sale of 4,500,000 Shares of Common Stock
4. Lotus Pharmaceuticals Retains Sichenzia Ross Friedman Ference LLP as General Legal Counsel
5. ISTA Pharmaceuticals Reports Positive Preliminary Results from its Phase 1/2 Clinical Study of Bepotastine Besilate Nasal Spray for the Treatment of Symptoms Associated with Seasonal Allergic Rhinitis
6. MAP Pharmaceuticals Announces Exercise of Over-Allotment Option and Closing of Underwritten Offering of Common Stock
7. Savient Pharmaceuticals Announces Dismissal of Class Action Lawsuit
8. Jiangbo Pharmaceuticals Announces Fourth Quarter and Fiscal Year 2010 Results
9. Transcept Pharmaceuticals to Present at BIO Investor Forum
10. MAP Pharmaceuticals, Inc. Announces Pricing of Underwritten Registered Offering of Common Stock
11. Qualitest Pharmaceuticals Selects TrackWise® for Comprehensive Enterprise Quality and Document Management

Post Your Comments:

(Date:5/22/2013)... CLEVELAND , May 22, 2013 /PRNewswire/ ... Software,s enterprise content management (ECM) ... Meditech,s Hospital Information System . These organizations ... IT system and will use OnBase to ... corporate initiatives. (Logo: ...

(Date:5/22/2013)... STEPh, Inc., a full service medical communications ... web site ( http://www.stephreports.com ) dedicated to ... STEPh Reports STEPh Reports are comprehensive critical ... STEPh Report assesses the competitive landscape by individual drug ... and specific key issues. STEPh Reports are written by ...

(Date:5/22/2013)... , May 22, 2013 Life Line ... screening services announced today the creation of a unique ... . MCM is a population health ... MCM,s growing list of clients. These important expanded services ... chronic conditions earlier. Effective prevention reduces cost of care ...

Breaking Medicine Technology:Three New Health Systems Integrate Hyland Software's OnBase with Meditech Hospital Information System 2 Three New Health Systems Integrate Hyland Software's OnBase with Meditech Hospital Information System 3 Scientific and Technical Evaluation of Pharmaceuticals, Inc. [STEPh, Inc.], Launches New Competitive Intelligence Web Site 2 Life Line Screening and MCM Solutions for Better Health Announce New Partnership 2

[0] Three New Health Systems Integrate Hyland Software's OnBase with Meditech Hospital Information System [0] Scientific and Technical Evaluation of Pharmaceuticals, Inc. [STEPh, Inc.], Launches New Competitive Intelligence Web Site [0] Life Line Screening and MCM Solutions for Better Health Announce New Partnership

... for prostate cancer treatment medications from Dendreon and ... with advanced prostate cancer were prolonged almost four ... The drug, which could reach the market in 2011, is ... to change clinical practice by providing a new treatment option ...

... ( www.pneumrx.com ), a medical device company dedicated to ... disease, today announced that it has received CE Mark ... System to treat the later stages of emphysema. ... invasive device intended to improve lung function in emphysema ...

Cached Medicine Technology:Robotic Prostatectomy Expert Dr. David Samadi, MD Discusses Prostate Cancer Treatment Drug Abiraterone 2 PneumRx, Inc. Announces CE Mark Approval for Its RePneu® Lung Volume Reduction Coil (LVRC™) System 2

Robotic Prostatectomy Expert Dr. David Samadi, MD Discusses Prostate Cancer Treatment Drug Abiraterone PneumRx, Inc. Announces CE Mark Approval for Its RePneu® Lung Volume Reduction Coil (LVRC™) System

(Date:5/22/2013)... TWITTER: @the_USO & @SesameStreet are proud to ... in the next 6 months! , Today, the ... came together to show their heartfelt thanks to those who currently ... for distribution to our servicemen and women. The group was ... and the USO as well as the success of the ...

(Date:5/22/2013)... Zensah® Compression Apparel released a statement ... titled "Breast pain while running affects one-third of ... help." According to the article, a British study surveyed ... suffer from breast pain while running but do not ... , Zensah emphasizes the importance for women to ...

(Date:5/22/2013)... May 22, 2013 Successful Therapy ... Patricia O’Laughlin Psychotherapy in the Silver Lake community ... all ages as progression to existing Parents and ... ages into parenting therapy has always been suggested, ... O’Laughlin Psychotherapy now specializes in all aspects of ...

(Date:5/22/2013)... (PRWEB) May 22, 2013 Twenty student-led ... next year participating in an intensive startup accelerator designed ... products or services and create local jobs as part ... Each year the Edson initiative offers approximately 20 student ... space, mentorship and training to launch their for-profit, more-than-profit ...

(Date:5/22/2013)... Maureen Salamon HealthDay Reporter , , WEDNESDAY, May ... cause a great deal of suffering, but new research ... to something else entirely -- a smaller brain. , ... the risk of depression, scientists wanted to determine if ... difference in size -- about 2 percent -- isn,t ...

[0] The USO and Sesame Street Announce Spring Kick Off of World Tour at Biannual Care Package Service Project Event in DC [0] Zensah® Comments on New York Daily News Article Examining How Better Sports Bra Could Help Women Marathoners [0] Patricia O’Laughlin Psychotherapy of Los Angeles Now Seeing Adults, Teens and Young Children [0] ASU Announces Edson Student Entrepreneur Initiative’s 2013-2014 Cohort [0] Having Both Migraines, Depression May Mean Smaller Brain

... ... an occupational health nurse. , ... Franklin, Tenn. (Vocus) February 25, 2010 -- Kathy Dayvault, RN, MPH, ... than two decades of experience in occupational health and safety, Dayvault will provide support ...

... ... ... , ... , , , ...

... ... ... , , ... ...

... 1 March 2010 - Conventional antidepressant treatments generally require ... discovery of treatments with a more rapid onset is ... drug found to produce rapid improvement in mood was ... In a new issue of Biological Psychiatry , ...

... Ohio If the behavior of the seasonal form of ... chances are good that most strains of the pandemic H1N1 ... stockpiled for use against it. Researchers at Ohio State ... influenza virus, which first infected humans during the 1918 pandemic. ...

... ... , ... 2010 -- Screenings of inner-city Pittsburgh children show an alarming number of young asthmatics with ... are not being diagnosed or treated, according to a study led by researchers at Allegheny ...

Cached Medicine News:Health News:Occupational Health Expert Expands PureSafety's Growing Strategic Resources Team 2 Health News:Acuo Technologies Announces Enhanced Offerings That Facilitate Management of Non-DICOM Objects 2 Health News:Acuo Technologies Announces Enhanced Offerings That Facilitate Management of Non-DICOM Objects 3 Health News:Maria D. Solomon is Recognized by Continental Who’s Who Among Health Care Professionals 2 Health News:A new generation of rapid-acting antidepressants? 2 Health News:Pandemic flu, like seasonal H1N1, shows signs of resisting Tamiflu 2 Health News:Pandemic flu, like seasonal H1N1, shows signs of resisting Tamiflu 3 Health News:Pandemic flu, like seasonal H1N1, shows signs of resisting Tamiflu 4 Health News:AGH Study Shows High Rates of Poorly Controlled Asthma Among Inner-City Pittsburgh Children 2

Occupational Health Expert Expands PureSafety's Growing Strategic Resources Team Acuo Technologies Announces Enhanced Offerings That Facilitate Management of Non-DICOM Objects Maria D. Solomon is Recognized by Continental Who’s Who Among Health Care Professionals A new generation of rapid-acting antidepressants?Pandemic flu, like seasonal H1N1, shows signs of resisting Tamiflu AGH Study Shows High Rates of Poorly Controlled Asthma Among Inner-City Pittsburgh Children

Penicillin-Streptomycin-Glutamine (100X) liquid...

Contains 10,000 units of penicillin (base), 10,000 g of streptomycin (base), and 25 g of amphotericin B/ml utilizing penicillin G (sodium salt), streptomycin sulfate, and amphotericin B as Fungizone ...

...

Gentamicin is a selection antibiotic used for selection of a Bac-to-Bac recombinant expression bacmid following transposition. Gentamicin is provided as a solution at a concentration of 50 mg/ml....

Medicine Products:

Gibco Penicillin-Streptomycin-Glutamine (100X) liquid Gibco Antibiotic-Antimycotic (100X), liquid GENTAMICIN SULFATE, 100X Gibco Gentamicin Reagent Solution (50 mg/ml) liquid